catechin has been researched along with Aerobic Glycolysis, Oncologic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, S; Kashihara, H; Morine, Y; Nishi, M; Shimada, M; Takasu, C; Tokunaga, T; Wada, Y; Yamada, S | 1 |
1 other study(ies) available for catechin and Aerobic Glycolysis, Oncologic
| Article | Year |
|---|---|
Epigallocatechin‑3‑gallate hinders metabolic coupling to suppress colorectal cancer malignancy through targeting aerobic glycolysis in cancer‑associated fibroblasts.
Topics: Cancer-Associated Fibroblasts; Catechin; Colorectal Neoplasms; Humans; Neoplasms; Oxidative Coupling; Warburg Effect, Oncologic | 2022 |